MAMIFORT, 75/200 mg/8 g, intramamarna suspenzija, za krave u laktaciji
MAMIFORT, 75/200 mg/8 g, intramamarna suspenzija, za krave u laktaciji
Authorised
- Cloxacillin
- Ampicillin
Product identification
Medicine name:
MAMIFORT, 75/200 mg/8 g, intramamarna suspenzija, za krave u laktaciji
Active substance:
- Cloxacillin
- Ampicillin
Target species:
-
Cattle (lactating cow)
Route of administration:
-
Intramammary use
Product details
Active substance and strength:
-
Cloxacillin200.00/milligram(s)1.00Syringe
-
Ampicillin75.00/milligram(s)1.00Syringe
Pharmaceutical form:
-
Intramammary suspension
Withdrawal period by route of administration:
-
Intramammary use
-
Cattle (lactating cow)
-
Meat and offal7day
-
Milk3dayMlijeko iz liječenih četvrti ne smije se koristiti za hranu ljudi tijekom liječenja i još 6 mužnji nakon zadnje aplikacije, uz uvjet da se krave muze 2 x na dan
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QJ51CA51
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Croatia
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Laboratorios Syva S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
- Laboratorios Syva S.A.
Responsible authority:
- Ministry Of Agriculture Veterinary And Food Safety Directorate
Authorisation number:
- UP/I-322-05/19-01/76
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it
in another language below.
Croatian (PDF)
Published on: 15/02/2022
How useful was this page?:
